Southern Illinois University School of Medicine is a medical school located in Springfield, the capital of the U.S. state of Illinois. It is part of the Southern Illinois University system, which includes a campus in Edwardsville as well as the flagship in Carbondale.

During the past decade, Southern Illinois University School of Medicine conducted 309 clinical trials. In the 10-year time frame, 309 clinical trials started and 195 clinical trials were completed, i.e. on average, 63.1% percent of trials that started reached the finish line to date. In the past 5 years, 134 clinical trials started and 120 clinical trials were completed. i.e. 89.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Illinois University School of Medicine" #1 sponsor was "National Cancer Institute (NCI)" with 172 trials, followed by "Children's Oncology Group" with 92 trials sponsored, "Alliance for Clinical Trials in Oncology" with 46 trials sponsored, "SWOG Cancer Research Network" with 44 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 44 trials sponsored. Other sponsors include 183 different institutions and companies that sponsored additional 104 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Illinois University School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 228 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Children's Oncology Group" with 7 trials as a collaborator and "Pfizer" with 5 trials as a collaborator. Other collaborators include 103 different institutions and companies that were collaborators in the rest 96 trials.

According to Clinical.Site data, the most researched conditions in "Southern Illinois University School of Medicine" are "Recurrent Neuroblastoma" (19 trials), "Alzheimer Disease" (14 trials), "Recurrent Osteosarcoma" (14 trials), "Alzheimer's Disease" (13 trials) and "Recurrent Malignant Solid Neoplasm" (13 trials). Many other conditions were trialed in "Southern Illinois University School of Medicine" in a lesser frequency.

Most popular intervention types in "Southern Illinois University School of Medicine" are "Drug" (412 trials), "Other" (258 trials), "Biological" (165 trials), "Procedure" (150 trials) and "Radiation" (83 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (117 trials), "Quality-of-Life Assessment" (79 trials), "Questionnaire Administration" (65 trials), "Computed Tomography" (56 trials) and "Biospecimen Collection" (55 trials). Other intervention names were less common.

The vast majority of trials in "Southern Illinois University School of Medicine" are 501 trials for "All" genders, 45 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Southern Illinois University School of Medicine". undefined are not yet recruiting, 127 are recruiting, 168 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 203 completed trials in Southern Illinois University School of Medicine, 8 suspended trials, and 41 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Illinois University School of Medicine, 32 "Phase 1" clinical trials were conducted, 247 "Phase 2" clinical trials and 243 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 35 trials that are defined as “Not Applicable".

Southern Illinois University School of Medicine has several departments that took part in Clinical trials: "Simmons Cooper Cancer Institute" - 32 trials, "Southern Illinois University Neurology and Pharmacology" - 2 trials, "SIUSOM - Division of Urology" - 2 trials